Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice (Q85939792)
Jump to navigation
Jump to search
scientific article published on 10 November 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice |
scientific article published on 10 November 2014 |
Statements
Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice (English)
10 November 2014